1. Home
  2. GL vs RGEN Comparison

GL vs RGEN Comparison

Compare GL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GL
  • RGEN
  • Stock Information
  • Founded
  • GL 1900
  • RGEN 1981
  • Country
  • GL United States
  • RGEN United States
  • Employees
  • GL N/A
  • RGEN N/A
  • Industry
  • GL Life Insurance
  • RGEN Medical/Dental Instruments
  • Sector
  • GL Finance
  • RGEN Health Care
  • Exchange
  • GL Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • GL 10.4B
  • RGEN 9.1B
  • IPO Year
  • GL N/A
  • RGEN N/A
  • Fundamental
  • Price
  • GL $122.61
  • RGEN $158.99
  • Analyst Decision
  • GL Buy
  • RGEN Buy
  • Analyst Count
  • GL 10
  • RGEN 11
  • Target Price
  • GL $135.50
  • RGEN $180.63
  • AVG Volume (30 Days)
  • GL 593.8K
  • RGEN 652.6K
  • Earning Date
  • GL 02-05-2025
  • RGEN 02-20-2025
  • Dividend Yield
  • GL 0.78%
  • RGEN N/A
  • EPS Growth
  • GL 18.57
  • RGEN N/A
  • EPS
  • GL 11.94
  • RGEN N/A
  • Revenue
  • GL $5,778,069,000.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • GL N/A
  • RGEN $2.28
  • Revenue Next Year
  • GL $5.05
  • RGEN $9.69
  • P/E Ratio
  • GL $10.27
  • RGEN N/A
  • Revenue Growth
  • GL 6.07
  • RGEN 0.33
  • 52 Week Low
  • GL $38.95
  • RGEN $113.50
  • 52 Week High
  • GL $129.18
  • RGEN $203.13
  • Technical
  • Relative Strength Index (RSI)
  • GL 57.26
  • RGEN 53.41
  • Support Level
  • GL $121.41
  • RGEN $143.83
  • Resistance Level
  • GL $125.43
  • RGEN $169.00
  • Average True Range (ATR)
  • GL 2.84
  • RGEN 5.95
  • MACD
  • GL -0.29
  • RGEN -0.24
  • Stochastic Oscillator
  • GL 66.06
  • RGEN 61.46

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: